Downie M M T, Sanders D A, Maier L M, Stock D M, Kealey T
Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital Box 232, Hills Road, Cambridge CB2 2QR, UK.
Br J Dermatol. 2004 Oct;151(4):766-75. doi: 10.1111/j.1365-2133.2004.06171.x.
Nuclear hormone receptors are important in the regulation of epidermal differentiation and have been implicated in lipid metabolism. In particular, there is evidence suggesting that the activation of peroxisome proliferator-activated receptors (PPARs) is an important factor in the regulation of sebocyte lipogenesis.
To determine the role of PPARs, farnesoid X receptor (FXR) and other orphan nuclear hormone receptors in sebaceous gland function in vitro by investigating the biochemical effects of appropriate ligands, and by establishing the RNA and protein expression patterns of a number of nuclear receptors in sebaceous glands ex vivo.
Human chest sebaceous glands were maintained in vitro as freshly isolated and as 7-day cultured whole organs. We then studied the effects of appropriate ligands on the glandular rates of lipogenesis and DNA synthesis, as well as determining the mRNA (reverse transcription-polymerase chain reaction) and protein expression patterns (immunohistochemistry/immunoblotting) of the nuclear hormone receptors of interest.
PPAR ligands, but not FXR ligands, inhibited sebaceous lipogenesis, in particular the PPARalpha ligands LY 171883 and WY 14643, and the PPARgamma ligands BRL 49653 and 15-deoxy-Delta-12,14-prostaglandin J(2). We detected RNA expression of PPARalpha, PPARbeta, PPARgamma, retinoid X receptor alpha, liver X receptor alpha (LXRalpha) and pregnane X receptor but not FXR in freshly isolated and 7-day maintained sebaceous glands. PPARalpha, PPARbeta, PPARgamma and LXRalpha protein were detected in nuclear extracts of sebaceous glands.
We conclude that activation of nuclear hormone receptors, in particular activation of PPARalpha and PPARgamma, can regulate lipogenesis in human sebaceous glands. As suppression of sebum secretion is associated with reduced acne activity, the nuclear hormone receptors involved may open new avenues in the development of novel acne treatments.
核激素受体在表皮分化调节中起重要作用,并且与脂质代谢有关。特别是,有证据表明过氧化物酶体增殖物激活受体(PPARs)的激活是调节皮脂腺细胞脂肪生成的一个重要因素。
通过研究合适配体的生化作用,以及建立体外培养的皮脂腺中多种核受体的RNA和蛋白质表达模式,来确定PPARs、法尼酯X受体(FXR)和其他孤儿核激素受体在体外皮脂腺功能中的作用。
将人胸部皮脂腺作为新鲜分离的和培养7天的全器官进行体外培养。然后我们研究了合适配体对腺体脂肪生成率和DNA合成的影响,并确定了感兴趣的核激素受体的mRNA(逆转录-聚合酶链反应)和蛋白质表达模式(免疫组织化学/免疫印迹)。
PPAR配体而非FXR配体抑制皮脂腺脂肪生成,特别是PPARα配体LY 171883和WY 14643,以及PPARγ配体BRL 49653和15-脱氧-Δ12,14-前列腺素J2。在新鲜分离的和培养7天的皮脂腺中,我们检测到了PPARα、PPARβ、PPARγ、视黄醇X受体α、肝X受体α(LXRα)和孕烷X受体的RNA表达,但未检测到FXR的表达。在皮脂腺的核提取物中检测到了PPARα、PPARβ、PPARγ和LXRα蛋白。
我们得出结论,核激素受体的激活,特别是PPARα和PPARγ的激活,可以调节人皮脂腺中的脂肪生成。由于皮脂分泌的抑制与痤疮活动的减轻有关,所涉及的核激素受体可能为新型痤疮治疗方法的开发开辟新途径。